| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335371 Combinations for the treatment of inflammatory disorders |
| 02/26/2008 | CA2463001C Solution based methacholine formulations |
| 02/26/2008 | CA2430592C New pharmaceutical compositions based on anticholinergics and dopamine agonists |
| 02/21/2008 | WO2008022038A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020586A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 02/21/2008 | WO2008020057A1 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | WO2008020042A1 Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases |
| 02/21/2008 | WO2007149568A3 N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide |
| 02/21/2008 | WO2007011941A9 Human anti-b7rp1 neutralizing antibodies |
| 02/21/2008 | WO2006136084A8 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 02/21/2008 | US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa |
| 02/21/2008 | US20080045603 Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity |
| 02/21/2008 | US20080045596 Ep2 Receptor Agonists |
| 02/21/2008 | US20080045565 Combinations Comprising Antimuscarinic Agents and Beta-Adrenergic Agonists |
| 02/21/2008 | US20080045549 Adenosine a2b receptor antagonists |
| 02/21/2008 | US20080045541 Dihydropyridinone Derivatives |
| 02/21/2008 | US20080045536 Fused heterocyclic compounds useful as kinase modulators |
| 02/21/2008 | US20080045531 Anti-inflammatory medicaments |
| 02/21/2008 | US20080045527 Immunomodulating Heterocyclic Compounds |
| 02/21/2008 | US20080045525 Piperazinyl-Pyridine Analogues |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2008 | US20080045473 Compositions and methods for oligonucleotide formulations |
| 02/21/2008 | US20080045449 Novel Lipid Mixtures For Synthetic Surfactants |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044455 Tonsillitus Treatment |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044405 Noble metal complex-mediated immunosuppression |
| 02/21/2008 | US20080044361 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide, with a simple monoclinic cell, and one or more adjuvants |
| 02/21/2008 | DE202007015419U1 Präparat zur Reduzierung von Viren, Keimen und Bakterien in Innenräumen als Spray A preparation for reduction of viruses, germs and bacteria indoors as a spray |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660707A1 Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure |
| 02/21/2008 | CA2660488A1 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | CA2658050A1 Diagnosis and treatment of cancer using anti-desmoglein 3 antibodies |
| 02/20/2008 | EP1889846A1 Purine derivatives as A2a agonists |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889622A1 Spiropiperidine compound and medicinal use thereof |
| 02/20/2008 | EP1888639A1 Methods for damaging cells using effector function of anti-dsc2 antibody |
| 02/20/2008 | EP1888584A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 02/20/2008 | EP1888527A1 Piperidines for the treatment of chemokine mediated diseases |
| 02/20/2008 | EP1888526A1 Piperidines for the treatment of chemokine mediated diseases |
| 02/20/2008 | EP1888033A2 Method and composition for treating inflammatory disorders |
| 02/20/2008 | EP1722771A4 Compositions and methods for preventing or treating an inflammatory response |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1131290B1 Piperidine ccr-3 receptor antagonists |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | EP0975347B1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/20/2008 | EP0938315B9 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 02/20/2008 | CN101128470A New compounds |
| 02/20/2008 | CN101128434A Amide derivatives |
| 02/20/2008 | CN101128196A Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases |
| 02/20/2008 | CN101125200A Application of interleukin 2 and its derivative in preparing medicine for treating bronchitis |
| 02/20/2008 | CN101125199A Application of interleukin 2 and its derivative in preparing medicine for treating rhinitis |
| 02/20/2008 | CN101125174A Traditional Chinese medicine pill for treating chronic pharyngitis |
| 02/20/2008 | CN101125156A Method for preparing compound senecio cannabifolius less composition and medical application |
| 02/20/2008 | CN101125153A Acanthopanax root granule and its preparation method |
| 02/20/2008 | CN101125141A Anticancer medicine composition and its application in preparing anticancer medicine |
| 02/20/2008 | CN100370252C Method for controlling quality of injection liquid or powder of |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/20/2008 | CN100369615C Medicinal composition for preventing and treating children respiratory system diseases and preparation method thereof |
| 02/20/2008 | CN100369608C Suspension spray for treating allergic rhinitis and its preparing method |
| 02/20/2008 | CN100369607C Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2431565C Pharmaceutical compositions based on anticholinergics and ciclesonide |
| 02/19/2008 | CA2369726C Powder inhaler for combined medicament |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/14/2008 | WO2008019302A1 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2008017638A1 Single enantiomer beta-agonists, methods for the production thereof and the use thereof as medication |
| 02/14/2008 | WO2008017637A1 Drug combinations for the treatment of respiratory tract diseases |
| 02/14/2008 | WO2008017126A1 Treatment of pulmonary disease conditions |
| 02/14/2008 | WO2008008493A3 Alkyne-substituted pyridone compounds and methods of use |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039499 Chemical Compounds |
| 02/14/2008 | US20080039493 Quinuclidine derivatives as M3 antagonists |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |